Atria Investments LLC Collegium Pharmaceutical, Inc Transaction History

Atria Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $126,746 - $232,231	-9,125 Reduced 44.89%	11,201 $183,000
Q4 2019 Feb 11, 2020	SELL	$10.7 - $22.24 $31,757 - $66,008	-2,968 Reduced 12.74%	20,326 $418,000
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $4,592 - $6,002	452 Added 1.98%	23,294 $267,000
Q2 2019 Aug 26, 2019	BUY	$10.62 - $16.59 $242,582 - $378,948	22,842 New	22,842 $260,000
Q2 2019 Aug 09, 2019	SELL	$10.62 - $16.59 $179,626 - $280,603	-16,914 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $64,803 - $89,331	4,772 Added 39.3%	16,914 $256,000
Q4 2018 Feb 12, 2019	SELL	$14.78 - $19.68 $46,778 - $62,287	-3,165 Reduced 20.68%	12,142 $208,000
Q3 2018 Oct 09, 2018	BUY	$14.16 - $24.3 $97,222 - $166,843	6,866 Added 81.34%	15,307 $226,000
Q2 2018 Jul 13, 2018	BUY	$21.79 - $28.29 $183,929 - $238,795	8,441 New	8,441 $201,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Atria Investments LLC with notifications on news.